Medical practice perspective: Identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain

Pain Medicine

Volumn 11, Issue 7, 2010, Pages 1001-1009

  Coffey, Robert J ^a   Owens, Mary L ^a   Broste, Steven K ^a   Dubois, Michel Y ^b   Ferrante, F Michael ^c   Schultz, David M ^d   Stearns, Lisa J ^e   Turner, Michael S ^f  

^a MEDTRONIC INC   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Medical Advanced Pain Specialists Minneapolis   (United States)

^e Center for Pain and Supportive Care   (United States)

^f Indianapolis Neurosurgical Group   (United States)

Author keywords

Intrathecal Drugs; Morphine; Mortality; Opioid; Pain

Indexed keywords

BUPIVACAINE; HYDROMORPHONE; INFUMORPH; MORPHINE; OPIATE; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

ARTICLE; DEVICE; DRUG DELIVERY SYSTEM; DRUG SAFETY; HEALTH CARE FACILITY; HEALTH INSURANCE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MORTALITY; PAIN; RESPIRATION DEPRESSION; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; DRUG OVERDOSE; FACTUAL DATABASE; INFUSION PUMP; INTRASPINAL DRUG ADMINISTRATION;

ANALGESICS, OPIOID; DATABASES, FACTUAL; DRUG OVERDOSE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; PAIN; RISK FACTORS;

EID: 77955143546     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00889.x     Document Type: Article

References (30)

1. Coffey RJ, Owens ML, Broste SK. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat non-cancer pain. Anesthesiology 2009, 111:881-91.
2. Ramirez LF, Thisted R. Using a national health care data base to determine surgical complications in community hospitals: Lumbar discectomy as an example. Neurosurgery 1989, 25:218-25.
3. Ramirez LF, Thisted R. Complications and demographic characteristics of patients undergoing lumbar discectomy in community hospitals. Neurosurgery 1989, 25:226-31.
4. Oldridge MD, Yuan Z, Stoll JE, Rimm AR. Lumbar spine surgery and mortality among Medicare beneficiaries, 1986. Am J Public Health 1994, 84:1292-8.
5. Rathmell JP, Matthew MJ. Death after initiation of intrathecal drug therapy for chronic pain. Anesthesiology 2009, 111:706-8.
6. Ellis DJ, Dissanayake S, McGuire D. Continuous intrathecal infusion of ziconotide for treatment of chronic malignant and nonmalignant pain over 12 months: A prospective, open-label study. Neuromodulation 2008, 11:40-9.
7. Rauck R, Wallace M, Leong M. A randomized double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006, 31:393-406.
8. Anderson V, Burchiel K. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999, 44:289-300.
9. Brown J, Klapow J, Doleys D, Lowery D, Tutak U. Disease-specific and generic health outcomes: A model for the evaluation of long-term intrathecal opioid therapy in noncancer low back pain patients. Clin J Pain 1999, 15:122-31.
10. Deer T, Chapple I, Classen A. Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Med 2004, 5:6-13.
11. Doleys DM, Brown J, Ness T. Multidimensional outcomes analysis of intrathecal, oral opioid, and behavioral-functional restoration therapy for failed back surgery syndrome: A retrospective study with 4 years' follow-up. Neuromodulation 2006, 9:270-83.
12. Rainov N, Heidecke V, Burkurt W. Long term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001, 22:862-71.
13. Shaladi A, Saltari MR, Piva B. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis. Clin J Pain 2007, 23:511-7.
14. Staats P, Whiteworth M, Baraka M. The use of implanted programmable infusion pumps in the management of non-malignant chronic low back pain. Neuromodulation 2007, 10:376-80.
15. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: A 3-year prospective study. Pain 2004, 109:242-9.
16. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996, 85:458-67.
17. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-83.
18. Klabunde C, Potosky A, Legler J, Warren J. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000, 53:1258-67.
19. Klabunde C, Warren J, Legler J. Assessing comorbidity using claims data-An overview. Med Care 2002, 40:26-35.
20. Deer T, Krames E, Hassenbusch S. Polyanalgesic consensus conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation 2007, 10:300-28.
21. Phillips DP, Barker GE, Eguchi MM. A steep increase in domestic fatal medication errors with use of alcohol and/or street drugs. Arch Intern Med 2008, 168:1561-6.
22. Eckholm E, Pierce O. Methadone rises as a painkiller with big risks. New York Times, August 17, 2008
23. Meier B. FDA weighs training to dispense narcotics. New York Times, August 17, 2008
24. Bennett G, Serafini M, Burchiel K. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 2000, 20:S12-36.
25. Hassenbusch SJ, Portenoy RK, Cousins M. Polyanalgesic consensus conference 2003: An update on the management of pain by intraspinal drug delivery-Report of an expert panel. J Pain Symptom Manage 2004, 27:540-63.
26. Hill CS. Guidelines for Treatment of Cancer Pain 1997, 25-6. The Texas Cancer Council's Workgroup on Pain Control in Cancer Patients, 2nd, edition, Austin, TX, Texas Cancer Council
27. Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008, 9:425-32.
28. Smith TJ, Staats PS, Deer T. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002, 20:4040-9.
29. Bailey PL, Lu JK, Pace NL. Effects of intrathecal morphine on the ventilatory response to hypoxia. N Engl J Med 2000, 343:1228-34.
30. Walker JM, Farney RJ, Rhondeau SM. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007, 3:455-61.